Log in
NASDAQ:ELOX

Eloxx Pharmaceuticals Stock Forecast, Price & News

$2.80
-0.02 (-0.71 %)
(As of 10/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$2.74
Now: $2.80
$2.86
50-Day Range N/A
52-Week Range
$1.44
Now: $2.80
$8.16
Volume12,615 shs
Average Volume123,389 shs
Market Capitalization$112.39 million
P/E RatioN/A
Dividend YieldN/A
Beta2.55
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial that focuses on the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.13 out of 5 stars

Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ELOX
CUSIPN/A
CIKN/A
Phone781 577 5300
Employees29

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.91 per share

Profitability

Net Income$-50,870,000.00

Miscellaneous

Market Cap$112.39 million
Next Earnings Date11/5/2020 (Confirmed)
OptionableOptionable
$2.80
-0.02 (-0.71 %)
(As of 10/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ELOX News and Ratings via Email

Sign-up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Eloxx Pharmaceuticals (NASDAQ:ELOX) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Eloxx Pharmaceuticals?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eloxx Pharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Eloxx Pharmaceuticals
.

When is Eloxx Pharmaceuticals' next earnings date?

Eloxx Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Eloxx Pharmaceuticals
.

How can I listen to Eloxx Pharmaceuticals' earnings call?

Eloxx Pharmaceuticals will be holding an earnings conference call on Thursday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Eloxx Pharmaceuticals' earnings last quarter?

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) released its quarterly earnings results on Thursday, August, 6th. The company reported ($0.20) EPS for the quarter, topping the Zacks' consensus estimate of ($0.22) by $0.02.
View Eloxx Pharmaceuticals' earnings history
.

Who are some of Eloxx Pharmaceuticals' key competitors?

Who are Eloxx Pharmaceuticals' key executives?

Eloxx Pharmaceuticals' management team includes the following people:
  • Dr. Gregory Williams M.B.A., Ph.D., MBA, CEO & Director (Age 61, Pay $586.7k)
  • Dr. Silvia Noiman M.B.A., Ph.D., MBA, Founder & Director (Age 64, Pay $40k)
  • Mr. Neil S. Belloff Esq., COO, Gen. Counsel & Corp. Sec. (Age 60)
  • Mr. Stephen MacDonald, VP of Fin. & Accounting, Principal Accounting Officer and Treasurer (Age 49)
  • Ms. Barbara Ryan, Investor Relations Officer

What is Eloxx Pharmaceuticals' stock symbol?

Eloxx Pharmaceuticals trades on the NASDAQ under the ticker symbol "ELOX."

How do I buy shares of Eloxx Pharmaceuticals?

Shares of ELOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Eloxx Pharmaceuticals' stock price today?

One share of ELOX stock can currently be purchased for approximately $2.80.

How big of a company is Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals has a market capitalization of $112.39 million. The company earns $-50,870,000.00 in net income (profit) each year or ($1.34) on an earnings per share basis. Eloxx Pharmaceuticals employs 29 workers across the globe.

What is Eloxx Pharmaceuticals' official website?

The official website for Eloxx Pharmaceuticals is www.eloxxpharma.com.

How can I contact Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals' mailing address is 950 WINTER STREET, WALTHAM MA, 02451. The company can be reached via phone at 781 577 5300 or via email at [email protected]

This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.